Dayton Children’s Hospital Taps Medline as Laboratory Prime Vendor

Agreement follows company’s supply chain solutions during the pandemic

Medline has been selected as Dayton Children’s Hospital’s laboratory prime vendor, entering into a multi-year agreement; an expansion of an existing partnership. For more than eight years, Medline has provided surgical and medical supplies to Dayton Children’s Hospital.

During the pandemic, Medline expanded its role with Dayton Children’s Hospital, helping the procurement team to improve supply chain and product standardization. Solutions included integrating laboratory supply procurement with the hospital’s broader supply chain operations, providing the hospital with a greater understanding of supply needs and available products, as well as potential product substitutions. As a result, the hospital was able to provide optimal care during the pandemic, as well as laboratory services and testing kits to other area hospitals and community residents.

“Because we were in constant communication with Medline, we were confident in our ability to maintain our supplies while also sharing resources with other hospitals and agencies when needed during the pandemic,” said Jennifer Nichols, laboratory finance manager for Dayton Children’s.

Dayton Children’s Hospital was selected by the State of Ohio to deliver regional laboratory care during the pandemic. The hospital also partnered with the Greater Dayton Area Hospital Association (GDAHA) to provide laboratory equipment and testing kits to various hospitals across nine different counties. In addition, Dayton Children’s Hospital opened three, drive-through COVID-19 testing sites for children and adults, and enacted a patient surge plan to care for adult patients when other hospitals did not have available beds.

“Our lab team truly went above and beyond to make sure we could provide all the testing our patients needed, as well as offer testing resources to the community as a whole,” said Melanie Wilson, senior director of laboratory services and medical imaging for Dayton Children’s.

“The keys to navigating these tough times were collaboration and communication,” said Wilson. “Through it all, our supply chain never let us down.”

 Learn more about Medline’s laboratory solutions.

SourceMedline
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version